Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

Healthcare’s Breaking Point: Doctors Battle Insurance Giants

by Team Lumida
December 12, 2024
in Health and Longevity
Reading Time: 2 mins read
A A
0
This 55-Year-Old’s Simple Routine Beats Millionaires at Anti-Aging
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • Insurance approval processes becoming more challenging for medical providers
  • Medicare Advantage denial rates increased to 7.4% in 2022 from 5.7% in 2019
  • Small practices struggling with administrative burdens and insurance complications
  • Doctors increasingly selling practices to larger healthcare networks

What Happened?

Following the tragic shooting of UnitedHealthcare executive Brian Thompson, healthcare providers are speaking out about their daily struggles with insurance companies. While universally condemning the violence, doctors describe a system that’s becoming increasingly difficult to navigate, with mounting paperwork, delayed approvals, and frequent claim denials affecting patient care.

Why It Matters?

The growing tension between medical providers and insurance companies reflects a deeper crisis in American healthcare. As doctors lose autonomy and face rising administrative burdens, many are forced to either join larger hospital systems or close their practices. This shift could significantly impact patient care and healthcare accessibility.

What’s Next?

The healthcare industry faces mounting pressure to reform insurance practices and reduce administrative burdens on medical providers. Recent events may accelerate discussions about healthcare system reforms and insurance company practices.

Previous Post

Bitcoin’s $10M+ Exodus: Whales Are Draining Exchanges

Next Post

Job Market Warning Signs: US Unemployment Claims Hit Two-Month Peak

Recommended For You

Generic Ozempic Wave Could Redraw the Global GLP-1 Market

by Team Lumida
2 hours ago
Generic Ozempic Wave Could Redraw the Global GLP-1 Market

Key Takeaways Powered by lumidawealth.com India is set to become the first major market to see a large-scale rollout of generic semaglutide, with at least a dozen major drugmakers...

Read more

Yoga Is the Longevity Habit Most People Underestimate

by Team Lumida
1 day ago
woman in black tank top and black pants bending her body on floor

Key takeaways Powered by lumidawealth.com Improves flexibility, balance, and joint health, reducing injury risk with age. Lowers stress and cortisol, supporting heart and metabolic health. Enhances nervous system regulation,...

Read more

Grip Strength Is a Longevity Biomarker

by Team Lumida
2 days ago
a person lifting a barbell in a gym

Key takeaways Powered by lumidawealth.com Lower grip strength is linked to higher mortality risk. It correlates with cardiovascular health, muscle mass, and frailty. Declining grip strength often signals system-wide...

Read more

Most “Longevity Drugs” Don’t Work the Way You Think

by Team Lumida
3 days ago
diagram

Key takeaways Powered by lumidawealth.com Most longevity drugs improve markers, not actual lifespan. Human evidence is weak for many popular compounds. Drug benefits are context-dependent — not universal. Lifestyle...

Read more

Walking After Meals Is a Simple Hack for Blood Sugar Control

by Team Lumida
4 days ago
woman walking on pathway during daytime

Key takeaways Powered by lumidawealth.com Just 10–15 minutes of walking after meals can lower post-meal blood sugar spikes. Light activity helps muscles absorb glucose without needing as much insulin....

Read more

Ozempic’s Patent Expiry Could Make India the Biggest Test Case for Cheap Weight-Loss Drugs

by Team Lumida
4 days ago
Ozempic’s Patent Expiry Could Make India the Biggest Test Case for Cheap Weight-Loss Drugs

Key takeaways Powered by lumidawealth.com India is about to become a major generic GLP-1 market, with multiple drugmakers preparing cheaper semaglutide launches after patent expiry. Prices could fall by...

Read more

Vinegar Before Meals May Help Control Blood Sugar

by Team Lumida
1 week ago
Several small glass bottles with orange liquid

Key takeaways Powered by lumidawealth.com 1–2 tablespoons of vinegar before meals can lower post-meal glucose spikes. Acetic acid slows carbohydrate digestion and glucose absorption. Studies show vinegar can improve...

Read more

Avocados Are the Metabolic Health Hack Most Diets Miss

by Team Lumida
1 week ago
sliced green avocado fruit

Key takeaways Powered by lumidawealth.com Avocados are rich in monounsaturated fats that support heart and metabolic health. High fiber content helps regulate blood sugar and appetite. They provide potassium,...

Read more

Fiber Before Meals Is the Natural GLP-1 Hack

by Team Lumida
1 week ago
Fiber Before Meals Is the Natural GLP-1 Hack

Key takeaways Powered by lumidawealth.com Fiber stimulates GLP-1, the same hormone targeted by popular weight-loss drugs. Eating fiber before meals reduces appetite and slows glucose spikes. It improves gut...

Read more

Walking After Meals Is the Longevity Hack

by Team Lumida
1 week ago
shallow focus photography of person walking on road between grass

Key takeaways Powered by lumidawealth.com A 10–15 minute walk after meals significantly lowers blood sugar spikes. Post-meal walking improves insulin sensitivity and metabolic health. Regular light movement after eating...

Read more
Next Post
Why Ignoring the U.S. Budget Gap Could Cost You Big

Job Market Warning Signs: US Unemployment Claims Hit Two-Month Peak

S&P 500’s Big Earnings Test: Will Tech Slowdown Derail Gains?

Markets on Edge: Stocks Slip as Job Data Rattles Investors

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Bitcoin Plunges to $64K Amid U.S. Tech Stock Turmoil

Crypto Miners Riding the AI Wave Are Leaving Bitcoin Behind

October 20, 2025
Lucid Group Q2 2024 Earnings Highlights: Record Deliveries Amidst Efficiency Gains

Lucid Group Q2 2024 Earnings Highlights: Record Deliveries Amidst Efficiency Gains

August 6, 2024
a black square with a blue logo on it

Meta Restructures AI Group into Four Teams to Accelerate Pursuit of Superintelligence

August 20, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018